Published in Blood Weekly, December 2nd, 2004
According to a study from the United States, "A novel class of pure antiestrogens, 1,1-dichloro-2,2,3-triarylcyclopropanes (DTACs), lack estrogenic activity in a mouse uterotrophic assay and inhibit the growth of estrogen-sensitive MCF-7 breast cancer cells (Day et al., 1991).
"Reporter assays were used to evaluate the effects of the DTACs on estrogen receptor alpha(ERalpha)-mediated transcription from either classic estrogen-response elements (EREs) or nonclassic AP-1 elements."
"Among the DTACs tested," reported P. Cheng and coworkers, "only the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.